JP2025506484A5 - - Google Patents

Info

Publication number
JP2025506484A5
JP2025506484A5 JP2024547471A JP2024547471A JP2025506484A5 JP 2025506484 A5 JP2025506484 A5 JP 2025506484A5 JP 2024547471 A JP2024547471 A JP 2024547471A JP 2024547471 A JP2024547471 A JP 2024547471A JP 2025506484 A5 JP2025506484 A5 JP 2025506484A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506484A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012949 external-priority patent/WO2023154528A1/en
Publication of JP2025506484A publication Critical patent/JP2025506484A/ja
Publication of JP2025506484A5 publication Critical patent/JP2025506484A5/ja
Pending legal-status Critical Current

Links

JP2024547471A 2022-02-11 2023-02-13 キラル化合物の立体選択的技術 Pending JP2025506484A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263309467P 2022-02-11 2022-02-11
US63/309,467 2022-02-11
PCT/US2023/012949 WO2023154528A1 (en) 2022-02-11 2023-02-13 Stereoselective technologies for chiral compounds

Publications (2)

Publication Number Publication Date
JP2025506484A JP2025506484A (ja) 2025-03-11
JP2025506484A5 true JP2025506484A5 (enExample) 2026-02-24

Family

ID=87564999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547471A Pending JP2025506484A (ja) 2022-02-11 2023-02-13 キラル化合物の立体選択的技術

Country Status (5)

Country Link
US (1) US20250154190A1 (enExample)
EP (1) EP4476202A4 (enExample)
JP (1) JP2025506484A (enExample)
CN (1) CN118660876A (enExample)
WO (1) WO2023154528A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014010250A1 (en) 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
EP3094728B1 (en) 2014-01-16 2022-03-09 Wave Life Sciences Ltd. Chiral design
CN117965536A (zh) 2015-07-22 2024-05-03 波涛生命科学有限公司 寡核苷酸组合物及其方法
MA46427A (fr) 2015-10-09 2018-08-15 Wave Life Sciences Ltd Compositions d'oligonucléotides et procédés associés
US11013757B2 (en) 2016-06-03 2021-05-25 Wave Life Sciences Ltd. Oligonucleotides, compositions and methods thereof
WO2018098264A1 (en) 2016-11-23 2018-05-31 Wave Life Sciences Ltd. Compositions and methods for phosphoramidite and oligonucleotide synthesis
WO2018237194A1 (en) 2017-06-21 2018-12-27 Wave Life Sciences Ltd. Compounds, compositions and methods for synthesis
CN111108096A (zh) 2017-09-18 2020-05-05 波涛生命科学有限公司 寡核苷酸制备技术
JP2021521140A (ja) 2018-04-12 2021-08-26 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. オリゴヌクレオチド組成物及びその使用方法
CA3098624A1 (en) 2018-05-11 2019-11-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
AU2020241559A1 (en) 2019-03-20 2021-11-11 Wave Life Sciences Ltd. Technologies useful for oligonucleotide preparation
MX2021012981A (es) 2019-04-25 2022-01-18 Wave Life Sciences Ltd Composiciones de oligonucleotido y metodos de uso de las mismas.
WO2025213142A2 (en) * 2024-04-05 2025-10-09 Wave Life Sciences Ltd. Oligonucleotide compositions and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176015A1 (en) * 2009-05-13 2011-12-29 Gilead Sciences Inc Antiviral compounds
WO2014010250A1 (en) * 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
CA3082579A1 (en) * 2017-11-15 2019-05-23 Mirati Therapeutics, Inc. Kras g12c inhibitors
AU2019392928A1 (en) * 2018-12-06 2021-06-17 Wave Life Sciences Ltd. Oligonucleotide compositions and methods thereof

Similar Documents

Publication Publication Date Title
JP2022068302A5 (enExample)
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2023116721A5 (enExample)
JP2021169491A5 (enExample)
JP2024059739A5 (enExample)
JP2023022224A5 (enExample)
JP2024023385A5 (enExample)
JP2021028398A5 (enExample)
JP2024016014A5 (enExample)
JP2021038271A5 (enExample)
JP2022060295A5 (enExample)
JP2023100643A5 (enExample)
JP2020171301A5 (enExample)
JP2020120660A5 (enExample)
JP2024112817A5 (enExample)
JP2022537813A5 (enExample)
JP2024534771A5 (enExample)
JP2023085551A5 (enExample)
JP2025084837A5 (enExample)
JP2023011759A5 (enExample)
JP2020141705A5 (enExample)
JP2022022379A5 (enExample)
JP2024063214A5 (enExample)